Centerspace Reported Higher Q3 Blended Rent Spreads, Lower Retention, UBS Says
MT newswire2026/11/03 16:50Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
12:50 PM EST, 11/03/2026 (MT Newswires) -- Centerspace's (CSR) blended rent spreads improved year over year in Q3, although core funds from operations fell short of consensus estimates and same-store net operating income declined, UBS Securities said Tuesday in a note. Blended rent spreads were 1.7%, up 120 basis points from a year earlier, driven by significant improvement in both new and renewal lease spreads. However, retention declined year over year to 61.5%, according to the note. Average Q3 monthly rent growth was 2.4%, while average revenue per home increased 0.8%. These figures include the previously anticipated nearly $1 million full-year drag from Colorado RUBS regulatory changes, the note added. In Q3, Centerspace's same-store net operating income declined 2.7%, driven by flat same-store revenue and a 4.2% increase in same-store expenses. The increase included a one-time utility expense of $200,000. North Dakota and Rochester were its strongest markets in terms of same-store revenue growth, at 7.2% and 2.7%, respectively, while Denver remained weak. UBS has a neutral rating on Centerspace, with a $65 price target. The company's shares were down more than 2% in Tuesday afternoon trading. Price: 57.93, Change: -1.25, Percent Change: -2.10
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
格隆汇•2026/11/09 07:01

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
智通财经•2026/11/09 06:41

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
智通财经•2026/11/09 06:41

Crypto prices
MoreBitcoin
BTC
$74,042.84
-2.25%
Ethereum
ETH
$2,100.87
-5.86%
Tether USDt
USDT
$0.9988
+0.02%
BNB
BNB
$680.94
-2.37%
USDC
USDC
$0.9999
+0.00%
XRP
XRP
$1.09
-6.49%
Solana
SOL
$85.71
-3.65%
TRON
TRX
$0.3165
-1.18%
Zcash
ZEC
$1,208.72
-4.15%
Hyperliquid
HYPE
$74.06
-3.90%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now